Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "products" return 66 results.
Ceva creates 60 strong teams to support innovative vaccination services on farm and in the hatchery >
29 April 2013 Recent research showed Ceva that their customers want more than just good vaccines; they want 100% of their birds correctly vaccinated.
Ceva uses creative thinking in new approach to innovation in Industrial equity >
Libourne, France 2nd May 2013:
2013 reprodAction Scientific Meeting - April 16-17th >
“Management and reproduction of dairy heifers” May 2013, Libourne - France
Signature of a scientific collaboration protocol about avian influenza with South China Agricultural University >
Ceva, a socially responsible company committed to the well-being of the planet
Ceva signs a Joint-venture agreement in China to help control zoonoses >
Joint-venture with Jinyu Baoling will produce brucellosis vaccines in Inner Mongolia Libourne 13th June 2013,
Privexia® Launch >
It’s our great pleasure to announce the launch of Privexia® , the new endectocide from Ceva Animal Health Reg. No. G3915 (Act 36/1947). Privexia® contains 1% Moxidectin , a second generation macrocycl...
Monitoring the intake of a gumboro immune-complex vaccine administered in the hatchery. >
Its use and examples compared to the classical vaccination method.
The Relevance of Bursa Size in modern Poultry Production >
Author: Kobus van Heerden, Technical Marketing Manager – CEVA Santé Animale Co-Authors: Dr. Christophe Cazaban, Innovation Strategy Biology Business Unit - CEVA Santé Animale Dr. Branko Alva, Corpor...
Ceva conducts Global Vector Vaccine Symposium >
Ceva, a global leader in vector vaccines technology, hosted over 280 participants from 41 countries at its first Vector Vaccine Symposium on October 06-08, 2010.
Our Core Values >
CEVA South Africa is committed to the following core values: